Delivery Order SPE2DR25D2105-SPE2DR26F5UYB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $1,864.56. This firm fixed-price delivery order, with an ultimate completion date of October 27, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply support under its existing contract vehicle with DLA. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $11,531.50. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units, with a ceiling value of $3,136.98. This contract employs firm fixed-price pricing and is scheduled for completion by June 13, 2025. The award is unset-aside and represents a competitively awarded delivery order under AmerisourceBergen's existing federal procurement framework. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $6,657.98. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $34,744.87. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion on September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $5,543.64. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by October 16, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $9,728.31. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is due for completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $10,781.30 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price contract, with an ultimate completion date of July 25, 2025, represents a single delivery order under the company's broader pharmaceutical supply agreement. The award utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $7,330.39. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by May 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- SPE2DR25D2105Indefinite Delivery Contract
- SPE2DR25D2105-SPE2DR26F5UYBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $30,082.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete successfully in open federal procurement. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies an extensive range of medications and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates significant experience delivering specialty pharmaceuticals, brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.1k | 11/3/25 |